Our Pricing

How to Access NHS Weight Loss Injections Online

Published on: June 03, 2026

Understanding how to access NHS weight loss injections online UK can be challenging with current NHS supply constraints and strict eligibility criteria. At Cured Pharmacy, our UK-registered clinical team provides a streamlined alternative—offering the same MHRA-licensed treatments with transparent pricing, free online consultations under 3 minutes, and discreet home delivery.

NHS Weight Loss Injection Eligibility: Who Qualifies?

The NHS prescribes weight loss injections under strict NICE guidelines. To qualify through NHS pathways, you typically need a BMI of 35 or above (or 30 with weight-related health conditions such as type 2 diabetes or hypertension), plus documented evidence of unsuccessful weight loss attempts through diet and exercise programmes [1].

Current NHS availability remains severely limited due to national supply constraints and prioritisation protocols. Many NHS trusts have suspended new prescriptions for weight management, focusing resources on patients with type 2 diabetes. Even when eligible, waiting times can extend beyond 12 months in some regions [2].

For patients who meet clinical criteria but face NHS access barriers, registered online pharmacies like Cured Pharmacy offer the same MHRA-licensed medications through private prescription pathways, with clinical assessments completed by UK-registered prescribers.

How GLP-1 Weight Loss Injections Work

Weight loss injections prescribed both through NHS and private pathways belong to a class called GLP-1 receptor agonists. These medications mimic natural gut hormones that regulate appetite, blood sugar, and gastric emptying [3].

Tirzepatide (Mounjaro) represents the latest advancement, functioning as a dual GIP/GLP-1 receptor agonist. This dual mechanism produces enhanced metabolic effects compared to single-pathway alternatives. In the SURPASS-3 clinical trial, patients achieved an average 22.5% body weight reduction over 72 weeks on the highest dose—significantly exceeding results from earlier GLP-1 treatments [1].

Semaglutide-based treatments like Wegovy work through GLP-1 receptor activation alone. The STEP-1 trial demonstrated average weight loss of 14.9% over 68 weeks, establishing semaglutide as an effective option for patients who may not require the dual-action mechanism [4].

Clinical Mechanisms Explained

These medications slow gastric emptying, which prolongs feelings of fullness after meals. They also act on brain regions controlling appetite, reducing food cravings and portion sizes. Additionally, they improve insulin sensitivity and glucose metabolism, addressing metabolic factors that contribute to weight gain [3].

Online Prescription Process at Cured Pharmacy

Accessing NHS weight loss injections online through registered pharmacy services follows MHRA-compliant protocols. At Cured Pharmacy, the process begins with a comprehensive online clinical assessment completed in under 3 minutes. Our UK-registered prescribers review your medical history, current medications, weight management goals, and any contraindications.

Unlike NHS pathways requiring GP referrals and specialist appointments, our streamlined service provides prescriber decisions typically within 24 hours. If approved, your medication is dispensed from our GPhC-registered pharmacy (9012511) and delivered discreetly to your address with tracked shipping.

All treatments require ongoing clinical monitoring. Our prescribers assess your progress, adjust dosages as clinically indicated, and provide guidance on managing potential side effects. This mirrors NHS protocols while eliminating lengthy waiting times and access barriers.

What the Assessment Covers

Your online consultation evaluates BMI, weight history, previous weight loss attempts, cardiovascular health, thyroid function, and family history of medullary thyroid carcinoma or MEN 2 syndrome. Certain medical conditions require additional precautions or may contraindicate GLP-1 therapy, which our prescribers identify during assessment.

Mounjaro, Wegovy, and Saxenda: Treatment Options Compared

Cured Pharmacy dispenses the same MHRA-licensed weight loss injections available through NHS pathways, with transparent upfront pricing. Mounjaro (tirzepatide) starts from £135.00 offering the dual GIP/GLP-1 mechanism that produced superior weight loss outcomes in head-to-head trials [1].

Wegovy (semaglutide) provides a once-weekly injection schedule with well-established efficacy data from the STEP trial programme. Saxenda (liraglutide) requires daily injections but offers a lower starting price point for patients preferring gradual dose escalation.

Your UK prescriber determines the most appropriate treatment based on your medical profile, weight loss goals, injection preference, and budget. Unlike NHS protocols that may limit options due to formulary restrictions, private prescription pathways allow individualised treatment selection.

Dosing and Administration

All three treatments use pre-filled injection pens for subcutaneous administration. Mounjaro and Wegovy require one injection weekly, typically on the same day each week. Saxenda requires daily injections, with doses gradually increased over five weeks to minimise gastrointestinal side effects. Our pharmacy team provides full administration guidance with every prescription.

Managing Side Effects and Treatment Expectations

The most common side effects across GLP-1 treatments include nausea, diarrhoea, constipation, and abdominal discomfort, particularly during dose escalation phases. These effects typically diminish within 4-8 weeks as your body adjusts to the medication [3][4].

Clinical trials demonstrate that gradual dose titration significantly reduces gastrointestinal symptoms. Starting at lower doses and increasing incrementally—as prescribed by your clinician—allows your digestive system to adapt. Eating smaller, more frequent meals and avoiding high-fat foods can further minimise discomfort.

Serious side effects remain rare but require immediate medical attention. These include signs of pancreatitis (severe abdominal pain radiating to the back), gallbladder problems, kidney impairment, or allergic reactions. Our clinical team provides comprehensive safety information and 24/7 access to pharmacy support throughout your treatment journey.

Cost Transparency: NHS vs Private Prescription Pathways

NHS prescriptions for weight loss injections, when available, incur standard prescription charges (currently £135.00 per item in England, free in Scotland, Wales, and Northern Ireland). However, access remains extremely limited, with most trusts prioritising diabetic patients or suspending new weight management prescriptions entirely [2].

Private prescription costs reflect the true medication price without NHS subsidies. At Cured Pharmacy, Mounjaro starts from £135.00 with no hidden fees—the price you see before consultation is the price you pay. This transparent pricing model eliminates surprise costs and allows informed treatment decisions.

We guarantee the lowest prices in the UK for all weight loss treatments. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees procurement and pricing strategies to ensure patients receive genuine UK-licensed medications at competitive rates without compromising quality or service standards.

Scientific References

1. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. https://www.nice.org.uk/guidance/ta875 [accessed 13 August 2026]
3. Müller, T. D., et al. (2019). Glucagon-like peptide 1 (GLP-1). Molecular Metabolism, 30, 72–130. https://doi.org/10.1016/j.molmet.2019.09.010 [accessed 13 August 2026]
4. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, lifestyle modifications, and individual metabolic factors.